LION MEDICAL GROUP AS
Operating
Utvikling, forskning, produksjon, handel, import, eksport og
kommersialisering av produkter og tjenester innen helse, bioteknologi
og life science, samt virksomhet innen kunstig intelligens, digital
infrastruktur, datasentre, skytjenester, programvare, digitale medier,
e-handel og annen teknologi. Selskapet kan også utvikle, erverve, eie
og lisensiere teknologi og immaterielle rettigheter, samt eie,
investere i og utvikle selskaper og virksomheter med naturlig
tilknytning til dette.
FoU, produksjon, handel, import, eksport og kommersialisering av
produkter og tjenester innen helse, bioteknologi og life science, samt
virksomhet innen kunstig intelligens, digital infrastruktur,
datasentre, skytjenester, programvar.
Organization
- Chairman of the board
- Years since formation
- 5 years
- since May 7, 2021
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 1,000,000
- 1 share class
- Total number of shareholders
- 2
- persons
Financials
- Annual total result 2025
- -3,671
- NOK
- Total equity 2025
- -2,690
- NOK
Last update: Oct 26, 2026
Management
Board
| Name | Role | Shares |
|---|---|---|
| Chairman | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
| - | 70 % directly | |
HK | - | 30 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
| Ordinary shares | 700,000 | 70 % | |
HK | Ordinary shares | 300,000 | 30 % |
Last update: Sep 25, 2026
Financials
in NOK
Summary
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -3,671 | -8,969 | -7,231 | -7,370 |
Total assets | 2,310 | 982 | 9,950 | 17,181 |
Total liabilities | 5,000 | 0 | 0 | 0 |
Total equity | -2,690 | 982 | 9,950 | 17,181 |
P&L
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 3,671 | 8,969 | 7,231 | 7,370 |
Operating result | -3,671 | -8,969 | -7,231 | -7,370 |
Financial income/costs | 0 | 0 | 0 | -1 |
Profit before tax | -3,671 | -8,969 | -7,231 | -7,370 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -3,671 | -8,969 | -7,231 | -7,370 |
Balance overview
| Year | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
Total fixed assets | 0 | 0 | 0 | 0 |
Total current assets | 2,310 | 982 | 9,950 | 17,181 |
Total assets | 2,310 | 982 | 9,950 | 17,181 |
Short term debt | 0 | 0 | 0 | 0 |
Long term debt | 0 | 0 | 0 | 0 |
Total liabilities | 5,000 | 0 | 0 | 0 |
Contributed capital | 30,000 | 30,000 | 30,000 | 30,000 |
Retained earnings | -32,690 | -29,018 | -20,050 | -12,819 |
Total equity | -2,690 | 982 | 9,950 | 17,181 |
Total equity and liabilities | 2,310 | 982 | 9,950 | 17,181 |
Classification
21st company classification
BETA
Startup
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification